Veenvliet, J. V.: Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson’s Disease. The Journal of Neuroscience 36 (6), pp. 1794 - 1796 (2016)
Alexander Meissner and Aydan Bulut-Karslioglu from Max Planck Institute for Molecular Genetics participate in a new cluster of excellence: ImmunoPreCept.